gemcitabine,capecitabine,CYT-0851
cyteir therapeutics
['capecitabine', 'solid tumor', 'gemcitabine']
#asco23 | hall a | saturday 8am ct
phase 1 results of cyt-0851, a monocarboxylate transporter (mct) inhibitor, in combination with capecitabine (cape) or gemcitabine (gem) in advanced solid tumors
dejan juric, md #mgccatasco23
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.